UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 525

Sortiert nach

Polymer therapeutics-prospects for 21st century: The end of the beginning

Advanced drug delivery reviews, 2013-01, Vol.65 (1), p.60-70

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

Advanced drug delivery reviews, 2009-11, Vol.61 (13), p.1203-1213

2009

Link zum Volltext

Verfügbarkeit prüfen

Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities

Advanced drug delivery reviews, 2010-02, Vol.62 (2), p.272-282

2010

Link zum Volltext

Verfügbarkeit prüfen

Reduction Sensitive Poly(l‑glutamic acid) (PGA)-Protein Conjugates Designed for Polymer Masked–Unmasked Protein Therapy

Biomacromolecules, 2014-11, Vol.15 (11), p.4168-4177

2014

Link zum Volltext

Verfügbarkeit prüfen

Polymer–drug conjugates as nano-sized medicines

Current opinion in biotechnology, 2011-12, Vol.22 (6), p.894-900

2011

Link zum Volltext

Verfügbarkeit prüfen

Modulating angiogenesis with integrin-targeted nanomedicines

Advanced drug delivery reviews, 2017-09, Vol.119, p.101-119

2017

Link zum Volltext

Verfügbarkeit prüfen

The past, present, and future of breast cancer models for nanomedicine development

Advanced drug delivery reviews, 2021-06, Vol.173, p.306-330

2021

Link zum Volltext

Verfügbarkeit prüfen

Polymer therapeutics: Clinical applications and challenges for development

Advanced drug delivery reviews, 2009-11, Vol.61 (13), p.1117-1120

2009

Link zum Volltext

Verfügbarkeit prüfen

Current hurdles to the translation of nanomedicines from bench to the clinic

Drug delivery and translational research, 2022-03, Vol.12 (3), p.500-525

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined polymer-curcumin conjugate and ependymal progenitor/stem cell treatment enhances spinal cord injury functional recovery

Biomaterials, 2017-01, Vol.113, p.18-30

2017

Link zum Volltext

Verfügbarkeit prüfen

Polypeptide‐Based Conjugates as Therapeutics: Opportunities and Challenges

Macromolecular bioscience, 2017-01, Vol.17 (1), p.np-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation

Advanced drug delivery reviews, 2020-01, Vol.160, p.136-169

2020

Link zum Volltext

Verfügbarkeit prüfen

Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel

Biomaterials, 2011-05, Vol.32 (15), p.3862-3874

2011

Link zum Volltext

Verfügbarkeit prüfen

Molecular platforms for targeted drug delivery

International review of cell and molecular biology, 2019, Vol.346, p.1

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression

International journal of cancer, 2019-10, Vol.145 (8), p.2267-2281

2019

Link zum Volltext

Verfügbarkeit prüfen

Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics

Polymer chemistry, 2011-01, Vol.2 (9), p.1900

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinically-relevant and predictive cancer models for nanomedicine evaluation

Advanced drug delivery reviews, 2022-04, Vol.183, p.114140-114140, Article 114140

2022

Link zum Volltext

Verfügbarkeit prüfen

Polymer conjugates: nanosized medicines for treating cancer

Trends in biotechnology (Regular ed.), 2006, Vol.24 (1), p.39-47

2006

Link zum Volltext

Verfügbarkeit prüfen

An Offset Patterned Cross‐β Structure in Assemblies of C3‐Symmetric Peptide Amphiphiles

Chemistry : a European journal, 2024-02, Vol.30 (7), p.e202303194-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques

Advanced drug delivery reviews, 2024-04, Vol.207, p.115195-115195, Article 115195

2024

Link zum Volltext

Verfügbarkeit prüfen

Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment

Journal of controlled release, 2023-03, Vol.355, p.385-394

2023

Link zum Volltext

Verfügbarkeit prüfen

Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer

Journal of controlled release, 2021-04, Vol.332, p.10-20

2021

Link zum Volltext

Verfügbarkeit prüfen

Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives

Journal of controlled release, 2022-03, Vol.343, p.237-254

2022

Link zum Volltext

Verfügbarkeit prüfen

Polypeptide-corticosteroid conjugates as a topical treatment approach to psoriasis

Journal of controlled release, 2020-02, Vol.318, p.210-222

2020

Link zum Volltext

Verfügbarkeit prüfen

Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery

Drug discovery today, 2021-06, Vol.26 (6), p.1369-1381

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 525

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(456)
Mit Volltextzugriff
(500)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Polymer therapeutics-prospects for 21st century: The end of the beginning

Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines

Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities

Reduction Sensitive Poly(l‑glutamic acid) (PGA)-Protein Conjugates Designed for Polymer Masked–Unmasked Protein Therapy

Polymer–drug conjugates as nano-sized medicines

Modulating angiogenesis with integrin-targeted nanomedicines

The past, present, and future of breast cancer models for nanomedicine development

Polymer therapeutics: Clinical applications and challenges for development

Current hurdles to the translation of nanomedicines from bench to the clinic

Combined polymer-curcumin conjugate and ependymal progenitor/stem cell treatment enhances spinal cord injury functional recovery

Polypeptide‐Based Conjugates as Therapeutics: Opportunities and Challenges

Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation

Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel

Molecular platforms for targeted drug delivery

Characterization of triple‐negative breast cancer preclinical models provides functional evidence of metastatic progression

Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure–property relationships to better defined therapeutics

Clinically-relevant and predictive cancer models for nanomedicine evaluation

Polymer conjugates: nanosized medicines for treating cancer

An Offset Patterned Cross‐β Structure in Assemblies of C3‐Symmetric Peptide Amphiphiles

Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques

Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment

Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer

Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives

Polypeptide-corticosteroid conjugates as a topical treatment approach to psoriasis

Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery

Suchergebnisse filtern